Scott L. Burrows, CFO: Spyre Therapeutics SYRE Sell · Filed 10/02

Trade details

Type: Insider sale
Amount: $1,573,075
Shares · price: 17,500 sh · $89.89 a share
Held after: 79,762 sh
Stock: Spyre Therapeutics SYRE
Person: Scott L. BurrowsCFO
Trade date: 26/09/30
Filed: 26/10/02
Days to filing: 2 days

Sold 18.0% of holdings

Share of holding sold: 18.0%

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 08/31~10/30

Scott L. Burrows's recent trades

Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$285.4K
3,071 sh
$285.4K
Filed 10/02
Traded 10/01
Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$193K
2,100 sh
$193K
Filed 10/02
Traded 10/01
Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$135.4K
1,500 sh
$135.4K
Filed 10/02
Traded 10/01
Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$53.4K
600 sh
$53.4K
Filed 10/02
Traded 10/01
Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$21.4K
229 sh
$21.4K
Filed 10/02
Traded 10/01